Summary: This past year, a bill was introduced in the California State Assembly that would make it easier for the California Attorney General to prosecute pharmaceutical companies for so-called "pay for delay" deals. On January 1st, that bill, AB 824, became a law. My guest is the author of AB 824, California Assemblymember Jim Wood. We're talking about what it was like to guide a bill that the pharmaceutical industry came out against through the state legislature and see it signed into law.
